Skip to content

Study of Addiction Criteria in the Elderly

Study of Addiction Criteria in the Elderly

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03509077
Acronym
CAPA
Enrollment
120
Registered
2018-04-26
Start date
2018-06-19
Completion date
2019-06-19
Last updated
2019-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Disorder

Keywords

geriatric, addiction

Brief summary

Patients over 65 years old who are exposed to alcohol or benzodiazepines will be recruited through the Fragility Assessment and Addictions Prevention Day Hospital, the Addiction Service and the Geriatric Post-Emergency Department. Toulouse University Hospital. The investigators will study descriptively the frequency of substance use disorder and the frequency of DSM-5 criteria associated with this diagnosis in a population of elderly subjects.

Detailed description

The hypothesis of this research is that some of the DSM-5 criteria for substance use disorder are more appropriate than others in people over 65 years of age. This study therefore aims to describe the frequency of the DSM-5 criteria for the substance use disorder in a population over 65 years of age and to link it secondarily to the severity of the addiction. The study is a descriptive study of a population of subjects over 65 years old. It aims to search for addiction criteria in this population by formulating the hypothesis of an addictive vulnerability relating to certain risk factors. To sensitize the detection of criteria, we chose among older subjects those who are most at risk because they are more exposed to the vulnerability factor relative to this population (physical disability, loss of autonomy, loneliness).

Interventions

None listed

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* To be over 65 * Have given your non-oral opposition to participate in research * Mini-Mental State Examination (MMSE) greater than or equal to 24 * Be part of one of the 3 inclusion services of the University Hospital of Toulouse * For 12 months, have daily consumption of benzodiazepine (at least once a day) and / or have excessive alcohol consumption as recommended by the American Geriatric Society (more than one unit of alcohol per day) ).

Exclusion criteria

* Patient refusing to participate in the study * MMSE less than 24 * Acute decompensation of a psychiatric disorder * Impossibility to understand or speak French * Patient under the protection of justice

Design outcomes

Primary

MeasureTime frameDescription
The number of DSM-5 criteria1 hourThe number of DSM-5 criteria for substance use disorder in the patient assessment. The number of DSM-5 criteria is a method of problematic substance use leading to clinically significant impairment or impairment characterized by the presence of at least two of the following manifestations over a 12-month period

Secondary

MeasureTime frameDescription
The Mini-GDS : a screening tool1 hourThe diagnosis of depression will be made using a screening tool, the Mini-GDS, performed in routine clinical practice as part of the assessment at the day hospital for frailty and addiction prevention. The Mini-GDS includes 4 items rated at one point depending on the answer. A higher score 1 makes it possible to suspect the existence of a depression.

Countries

France

Contacts

Primary ContactJuliette Salles, MD
salles.j@chu-toulouse.fr05 34 55 75 24
Backup ContactIsabelle Olivier, PhD
olivier.i@chu-toulouse.fr05 61 77 70 51

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026